Studi Clinici Lp(A)

Emerging Lipoprotein(a) Therapies: What’s Next? | Michelle O’Donoghue, MD, MPH

APOLLO Trial Finds Experimental Therapy Reduces Lipoprotien(a) By Up To 98% (For Healthcare Profs)

Cleveland Clinic

Lipoprotein A: A Cardiovascular Risk Factor Commonly Ignored

The Role of Lp(a) in Cardiology: Clinic, Echo and Cath Labs

MonteHeart Lectures

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

How to Lower Lipoprotein a (LPa) Naturally?

Heart Fit Clinic

ESC 23: OCEAN(a)-DOSE: Olpasiran in Patients with Atherosclerotic CVD and Elevated LP(a)

Radcliffe Cardiology

Lipoprotein(a) Clinical Trials: SLN 360

Family Heart Foundation

Lp(a) explained

The Heart Doctor

Importance of Lipoprotein(a) Screening and Testing

American Heart Association

Elevated Lipoprotein “little a”. What's the best treatment for Lp(a)?

Cleveland Clinic-Led Trial Finds Experimental Therapy Reduces Lipoprotien(a) By Up To 98%

Cleveland Clinic

Lipoprotein(a) Clinical Trials: Olpasiran

Family Heart Foundation

What elevated Lipoprotein(a) clinical trials are on the horizon?

Family Heart Foundation

Lp(a) vs. LDL - How to Manage Lp(a) Part 1

Dr. Ford Brewer

Technology Series/Medical-Lp(a)

DOIM GR 9/26/24: Lipoprotein(a): Research Rarity to Therapeutic Target

VCU Internal Medicine VCUHS

ACC 22: APOLLO FIH Study to Investigate siRNA in Raised Lipoprotein(a) | Dr Steven E Nissen

Radcliffe Cardiology

OCEAN(a)-DOSE Trial: Using Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

Emory Cardiology

Lipoprotein (a) and New Clinical Trials

Johnson Francis, MBBS, MD, DM